Home › Funds › Palo Alto Investors LP › MDGL
Palo Alto Investors LP position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Palo Alto Investors LP reported holding 1,787 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$901K, representing 0.13% of its reported portfolio and ranking #50 among its reported holdings. Palo Alto Investors LP has disclosed MDGL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's MDGL position evolved
Palo Alto Investors LP first disclosed a stake in MDGL in Q1 2026 at 1,787 shares (US$935K). The position peaked in Q2 2026 at 1,787 shares, worth US$960K. Across 3 filings, Palo Alto Investors LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,787 shares valued at US$901K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.79K | $935.44K | New |
| Q2 2026 | 1.79K | $959.53K | Hold |
| Q3 2026 | 1.79K | $900.58K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDGL and 13F data
MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.08B), Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$993.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDGL
- BAKER BROS. ADVISORS LP 2.14M sh · $1.08B · Q3 2026
- Jupiter Topco LLC 1.94M sh · $1.04B · Q2 2026
- Janus Henderson Group 1.97M sh · $993.87M · Q3 2026
- Avoro Capital Advisors LLC 1.83M sh · $923.93M · Q3 2026
- PAULSON & CO. INC. 1.49M sh · $751.72M · Q3 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 337.04K sh · $169.85M · Q3 2026
- RTW INVESTMENTS, LP 312.82K sh · $157.65M · Q3 2026
- Rock Springs Capital Management LP 177.25K sh · $89.33M · Q3 2026
- Hood River Capital Management LLC 170.68K sh · $86.02M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held MDGL?
Palo Alto Investors LP has disclosed MDGL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Palo Alto Investors LP's current position in MDGL?
As of Q3 2026, Palo Alto Investors LP holds 1.79K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $900.58K, representing 0.13% of its reported portfolio and ranking #50.
Has Palo Alto Investors LP been buying or selling MDGL?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in MDGL. The position peaked in Q2 2026 at 1.79K shares.
Which other funds hold MDGL?
Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, Jupiter Topco LLC, Janus Henderson Group, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.